The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells
about
Tryptophan metabolism, disposition and utilization in pregnancyTrial watch: IDO inhibitors in cancer therapyTargeted Deletion of Kynurenine 3-Monooxygenase in Mice: A NEW TOOL FOR STUDYING KYNURENINE PATHWAY METABOLISM IN PERIPHERY AND BRAINConstitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR.Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer.Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosisIDO inhibits a tryptophan sufficiency signal that stimulates mTOR: A novel IDO effector pathway targeted by D-1-methyl-tryptophan.Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinaseInvolvement of the kynurenine pathway in human glioma pathophysiology.Effects of Treg cells and IDO on human epithelial ovarian cancer cells under hypoxic conditionsCancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenaseFludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells.Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysisRespiratory Syncytial Virus-Infected Mesenchymal Stem Cells Regulate Immunity via Interferon Beta and Indoleamine-2,3-DioxygenasePreclinical evaluation of HIV eradication strategies in the simian immunodeficiency virus-infected rhesus macaque: a pilot study testing inhibition of indoleamine 2,3-dioxygenase.Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis.Amino acid auxotrophy as a system of immunological control nodes.The end of the road for the tryptophan depletion concept in pregnancy and infection.A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patientsRegulatory T cells in HIV infection: can immunotherapy regulate the regulator?Microenvironmental clues for glioma immunotherapy.Shaping the glioma immune microenvironment through tryptophan metabolism.Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators.Immune checkpoint inhibitors: a patent review (2010-2015).Major developments in the design of inhibitors along the kynurenine pathway.Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells.Utilizing Salmonella to treat solid malignancies.Expression and regulation of immune-modulatory enzyme indoleamine 2,3-dioxygenase (IDO) by human airway epithelial cells and its effect on T cell activationAn untargeted global metabolomic analysis reveals the biochemical changes underlying basal resistance and priming in Solanum lycopersicum, and identifies 1-methyltryptophan as a metabolite involved in plant responses to Botrytis cinerea and PseudomoEvaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging.P53 prevent tumor invasion and metastasis by down-regulating IDO in lung cancer.Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.No patient left behind: The promise of immune priming with epigenetic agents.Platform-independent gene expression signature differentiates sessile serrated adenomas/polyps and hyperplastic polyps of the colon.The inhibition of indoleamine 2, 3-dioxygenase 1 by connexin 43.
P2860
Q26783616-4EA26781-3EA5-4FE0-A2C8-1F955DA02AFFQ27006866-B52D2711-EEC1-4D85-AF7B-E926642EA623Q29306917-6CF6DB1B-E267-40C7-BDA3-AA24CA4D414EQ33572246-B6CBFCD5-2580-4456-A886-0F7823DC2660Q33635038-908A1148-4361-423B-AAB7-7F6A3D0D8D31Q33898659-3A93900A-734A-4D4B-BE66-EF83D9B9743AQ34319398-D3CB4D7C-6A0F-4D83-AD07-3112A92A2190Q34427452-EEE55E09-60EE-42E4-919E-92F1731E6521Q34451033-528FA375-957C-4BA5-89C4-385B0550BB01Q34556982-05B366EA-4C3D-4F2D-B083-E929B69B41C6Q34731353-733EC1F9-457C-4DED-8D02-6CDD43E80615Q34913785-73904907-FF1A-4458-9942-8B68FA65B54FQ35109049-BC83C8B6-AF24-4315-8543-0C2666C974E9Q35184110-3072F132-FD33-4DF8-A000-D18B7DC9F820Q35739397-FF95DD19-FD98-42B7-AAB7-2F7DBF8F33FAQ35960211-9AD585BF-CF81-4469-9215-1E68282D0A64Q36101138-425CFA30-8020-46B7-ABA3-A3C8ECB56964Q36151400-A113F753-709F-4C8E-9AE4-359D9A57874AQ36554031-1C5D0997-F9A4-4714-9473-021D90EE6A50Q36953989-7F74CB3A-11B1-4729-8E83-5976818E9709Q36970801-62135AB3-3D32-49D7-A061-6C616D792262Q37050204-E4FEC573-89B1-4180-B71E-CF04ECF50329Q37316541-BB642348-39AF-4C8A-B054-A597BAF7672BQ38068406-134AC294-2EDC-4D84-9C5B-B824967AB5DAQ38194054-CF5A8A17-C70D-47CA-8FDF-2DD6A6B03CBAQ38233070-9DEF9FC4-D310-4B34-9238-477A98942EE4Q38719858-89F3B8C6-C6F3-4F79-8D45-EA89C37367AEQ38800588-7F1E5A77-78DC-4855-91AD-8F72D94C81FAQ38808400-01301E95-476E-4A79-B2AE-9DB33258A9D5Q38832886-792FF791-9408-47FF-A0AF-4FCF478576C6Q39121393-0B5AC220-5309-4916-84C8-BC8396299765Q39248906-4BF0CB40-AA62-407F-8FC8-2F090FF7CCA8Q39404674-F6EB5A8F-4DD6-48C3-90CD-392CEF954A1EQ41054645-8AC4E085-0136-4BA0-9095-EF600A8F2301Q41470807-3CA3790C-D6C2-4A62-8DB3-CCEE096E8433Q41551539-E25B30BB-DAE5-49AE-BCC1-C1DE24EA7264Q42089828-045ADFA1-A836-48C7-8B98-2F135F457A39Q46665179-FCF1D0B5-5817-4030-A7C2-ADEF35F69F64Q47111568-8AED6632-1340-4E98-AC29-894C110850EBQ47124037-0F893700-9461-4848-999B-93DA42635F55
P2860
The indoleamine-2,3-dioxygenase (IDO) inhibitor 1-methyl-D-tryptophan upregulates IDO1 in human cancer cells
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@ast
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@en
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@nl
type
label
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@ast
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@en
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@nl
prefLabel
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@ast
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@en
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@nl
P2093
P2860
P50
P3181
P1433
P1476
The indoleamine-2,3-dioxygenas ...... tes IDO1 in human cancer cells
@en
P2093
Christian Lutz
Katharina Ochs
Ulrike M Litzenburger
P2860
P304
P356
10.1371/JOURNAL.PONE.0019823
P407
P577
2011-01-01T00:00:00Z